BGNE, Target 69Flagpole breakout to a lower side. possibly to going to much earlier lower zone of 69
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.6 EUR
−800.71 M EUR
2.23 B EUR
918.83 M
About BEIGENE, LTD.
Sector
CEO
John V. Oyler
Headquarters
George Town
Website
Founded
2010
FIGI
BBG00LNHN914
BeOne Medicines Ltd. Is a global oncology company, which engages in providing pharmaceutical products. Its medicines include BRUKINSA, TEVIMBRA, and PARTRUVIX. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange BEONE MEDICINES LTD. stocks are traded under the ticker 49B.
We've gathered analysts' opinions on BEONE MEDICINES LTD. future price: according to them, 49B price has a max estimate of 27.85 EUR and a min estimate of 15.32 EUR. Watch 49B chart and read a more detailed BEONE MEDICINES LTD. stock forecast: see what analysts think of BEONE MEDICINES LTD. and suggest that you do with its stocks.
Yes, you can track BEONE MEDICINES LTD. financials in yearly and quarterly reports right on TradingView.
BEONE MEDICINES LTD. is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
49B earnings for the last quarter are −0.08 EUR per share, whereas the estimation was −0.08 EUR resulting in a −3.23% surprise. The estimated earnings for the next quarter are −0.07 EUR per share. See more details about BEONE MEDICINES LTD. earnings.
BEONE MEDICINES LTD. revenue for the last quarter amounts to 900.34 M EUR, despite the estimated figure of 877.20 M EUR. In the next quarter, revenue is expected to reach 992.04 M EUR.
49B net income for the last quarter is −109.33 M EUR, while the quarter before that showed −112.51 M EUR of net income which accounts for 2.83% change. Track more BEONE MEDICINES LTD. financial stats to get the full picture.
No, 49B doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 9, 2025, the company has 10.00 K employees. See our rating of the largest employees — is BEONE MEDICINES LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BEONE MEDICINES LTD. EBITDA is −656.54 M EUR, and current EBITDA margin is −45.55%. See more stats in BEONE MEDICINES LTD. financial statements.
Like other stocks, 49B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BEONE MEDICINES LTD. stock right from TradingView charts — choose your broker and connect to your account.